EnGraft Technologies, Inc.
Biotechnology company · Marina Del Rey, California, United States
EnGraft Technologies, Inc. is a biotechnology company headquartered in Marina Del Rey, California, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2023.
EnGraft Technologies at a glance
What does EnGraft Technologies do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $1 million sold (2023).
Frequently asked questions about EnGraft Technologies
Where is EnGraft Technologies headquartered?
EnGraft Technologies, Inc. is headquartered in Marina Del Rey, California, United States.
What does EnGraft Technologies do?
EnGraft Technologies, Inc. is a biotechnology company.
When was EnGraft Technologies founded?
The earliest incorporation on record for EnGraft Technologies, Inc. is in 2023, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences